IDEAYA Biosciences, Inc. ( IDYA) - Key Metrics
IDYA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.10 | -$1.22 | -$1.77 | -$1.79 |
| 2026Q1 | $0.07 | -$1.11 | -$0.85 | -$0.86 |
| 2025Q4 | $0.12 | -$0.94 | -$1.02 | -$1.03 |
| 2025Q3 | $2.32 | $1.33 | $1.59 | $1.59 |
| 2025Q2 | $0 | -$0.88 | -$0.71 | -$0.71 |
IDYA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.64 |
| 2026Q1 | 0% | -7.50 |
| 2025Q4 | 0% | -9.19 |
| 2025Q3 | 0% | 5.04 |
| 2025Q2 | 0% | -5.97 |
IDYA
Price: $36.30
52 week price:
Earnings Per Share: -1.92 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 546053
Market Capitalization: 3.6 billion